The antibiotics R&D effort is broken. Here's one market solution that might fix it
Anyone even slightly familiar with antibiotics R&D over the last 10 years would quickly agree that the system is badly broken.
Big Pharma — with the …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
